Patents Assigned to The University of New South Wales
-
Publication number: 20190048375Abstract: The present invention relates to processes to make neosaxitoxin, and analogues and variants thereof, and intermediates in the production of neosaxitoxin in recombinant host cells. Neosaxitoxin and the analogues and variants thereof may be used in the production of pharmaceutical compositions.Type: ApplicationFiled: February 10, 2017Publication date: February 14, 2019Applicants: Bergen Teknologioverføring AS, University of New South Wales Innovations, University of New South Wales InnovationsInventors: Ralf Kellmann, Brett Neilan
-
Patent number: 7977097Abstract: A method of screening multiply transformed/transfected cells to identify those cells expressing at least two peptides or proteins of interest. The method comprising: 1. Simultaneously or sequentially transforming a cell with at least two different expression cassettes in which the gene of interest is linked via an IRES to a fluorescent marker gene. Each marker gene is different. 2. Providing conditions in which expression of the genes will occur. 3. Identifying cells expressing proteins by detecting the different fluorescent signals.Type: GrantFiled: November 24, 2000Date of Patent: July 12, 2011Assignee: The University of New South WalesInventors: Robert D. Gay, Noelle-Anne Sunstrom, Peter Philip Gray
-
Patent number: 7786260Abstract: An isolated polypeptide and immunogenic fragments thereof are described together with their variants and derivatives as novel immunogenic agents for treating or preventing Helicobacter infection in a mammalian host. The polypeptide comprises a C-terminal portion of a Helicobacter catalase, which portion lacks significant amino acid sequence identity with human catalase, wherein the polypeptide is other than full-length Helicobacter catalase.Type: GrantFiled: October 13, 2000Date of Patent: August 31, 2010Assignees: CSL Limited, The University of New South WalesInventors: Christopher Vincent Doidge, Elizabeth Ann Webb, Linda Joy Rothel, Phillip Sutton, Stuart Lloyd Hazell
-
Publication number: 20080131401Abstract: Method of enhancing a resident population of microorganism in a selected site of the gastrointestinal tract of an animal, the method comprising providing to the animal a selected modified or unmodified resistant startch or mixtures thereof in combination with one or more probiotic microogranisms such that upon ingestion the starch passes through the gastrointestinal tract substantially unutilized until it reaches the selected site where it is utilised by the resident and/or the probiotic microogranisms thereof causing an increase in number and/or activity of the microogranisms.Type: ApplicationFiled: February 12, 2002Publication date: June 5, 2008Applicants: The University of New South Wales, Burns Philp & Company, Burns Philp Research & Development PTY LTD, Commonwealth Scientific and Industrial Research Organisation, Arnott's Biscuits Limited, Gist-Brocades Australia PTY Limited, Goodman Fielder Ingredients LimitedInventors: Ian L. Brown, Patricia Lynne Conway, Anthony John Evans, Karl Anders Olof Henriksson, Kenneth J. McNaught, Xin Wang
-
Publication number: 20070282298Abstract: A method of and apparatus for controlling the speed of a rotary blood pump, which comprises the measuring the speed and/or power of said pump, calculating an array of system parameters derived from the measured speed, analysing these parameters, and if the analysis indicates ventricular collapse or imminent ventricular collapse, then the speed of said pump is altered, to minimise the risk of the collapse occurring. Preferably the analysis is done using a Classification and Regression Tree (CART) analysis.Type: ApplicationFiled: April 18, 2007Publication date: December 6, 2007Applicants: Ventrassist Pty Ltd, The University of New South WalesInventor: David Mason
-
Patent number: 6762295Abstract: Protective Helicobacter antigens, especially H. pylori antigens, and the use of these antigens for the treatment of or prevention of, gastroduodenal disease associated with H. pylori infection.Type: GrantFiled: December 23, 1997Date of Patent: July 13, 2004Assignees: CSL Limited, The University of New South WalesInventors: Christopher Vincent Doidge, Adrian Lee, Fiona Jane Radcliff, Dianna Margaret Hocking, Elizabeth Ann Webb
-
Patent number: 6630582Abstract: An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the catalase enzyme of Helicobacter bacteria, particularly the catalase enzyme of H. pylori or H. felis, or an immunogenic fragment thereof.Type: GrantFiled: January 7, 1998Date of Patent: October 7, 2003Assignees: University of New South Wales, CSL LimitedInventors: Christopher V. Doidge, Adrian Lee, Flona J. Radcliff, Stuart L. Hazell
-
Patent number: 6528498Abstract: Improved method of enhancing a population of one or more target micoorganisms in the gastrointestinal tract of an animal, the improvement comprising providing to the animal a selected modified or unmodified resistant starch or mixtures thereof, such that the one or more microorganisms will selectively utilize the starch and/or increase in number and/or activity in the gastrointestinal tract, either uniformly throughout the gastrointestinal tract or at specific site or regions.Type: GrantFiled: May 18, 2001Date of Patent: March 4, 2003Assignees: The University of New South Wales, Burns Philp & Company Limited, Burns Philp Research & Development PTY Ltd., Commonwealth Scientific and Industrial Research Organisation, Arnott's Biscuits Limited, Gist-Brocades Australia PTY Limited, Goodman Fiedler Ingredients LimitedInventors: Ian L. Brown, Patricia Lynne Conway, Karl Anders Olof Henriksson, Kenneth J. McNaught, Xin Wang
-
Publication number: 20020198175Abstract: Improved method of enhancing a population of one or more target micoorganisms in the gastrointestinal tract of an animal, the improvement comprising providing to the animal a selected modified or unmodified resistant starch or mixtures thereof, such that the one or more microorganisms will selectively utilize the starch and/or increase in number and/or activity in the gastrointestinal tract, either uniformly throughout the gastrointestinal tract or at specific site or regions.Type: ApplicationFiled: May 18, 2001Publication date: December 26, 2002Applicant: THE UNIVERSITY OF NEW SOUTH WALESInventors: Ian L. Brown, Patricia Lynne Conway, Karl Anders Olof Henriksson, Kenneth J. McNaught, Xin Wang
-
Patent number: 6468545Abstract: An antigenic preparation for use in the treatment of prevention of Helicobacter infection in a mammalian host, comprises the catalase enzyme of Helicobacter bacterial, particularly the catalase enzyme of H. pylori or H. felis, or an immunogenic fragment thereof.Type: GrantFiled: October 20, 1999Date of Patent: October 22, 2002Assignees: The University of New South Wales, CSL LimitedInventors: Christopher V. Doidge, Adrian Lee, Fona J. Radcliff, Stuart L. Hazell
-
Patent number: 6406703Abstract: The application discloses a method for the treatment of Heliobacter infection in a mammalian host, which comprises administration to said infected host of an immunologically effective amount of one or more Heliobacter antigen(s), optionally in association with a mucosal adjuvant.Type: GrantFiled: July 5, 2000Date of Patent: June 18, 2002Assignees: CSL Limited, The University of New South WalesInventors: Christopher Vincent Doidge, Adrian Lee
-
Patent number: 6348452Abstract: Method of enhancing a resident population of microorganism in a selected site of the gastrointestinal tract of an animal, the method comprising providing to the animal a selected modified or unmodified resistant starch or mixtures thereof in combination with one or more probiotic microorganisms such that upon ingestion the starch passes through the gastrointestinal tract substantially unutilized until it reaches the selected site where it is utilized by the resident and/or the probiotic microorganisms thereof causing an increase in number and/or activity of the microorganisms.Type: GrantFiled: January 29, 1999Date of Patent: February 19, 2002Assignees: The University of New South Wales, Burns Philp & Company, Burns Philp Research & Development PTY LTD, Commonwealth Scientific and Industrial Research Organisation, Arnott's Biscuits Limited, Gist-Brocades Australia PTY Limited, Goodman Fielder Ingredients LimitedInventors: Ian L. Brown, Patricia Lynne Conway, Anthony John Evans, Karl Anders Olof Henriksson, Kenneth J. McNaught, Xin Wang
-
Patent number: 6274567Abstract: Improved method of enhancing a population of one or more target microorganisms in the gastrointestinal tract of an animal, the improvement comprising providing to the animal a selected modified or unmodified resistant starch or mixtures thereof, such that the one or more microorganisms will selectively utilise the starch and/or increase in number and/or activity in the gastrointestinal tract, either uniformly throughout the gastrointestinal tract or at specific site or regions.Type: GrantFiled: May 10, 1999Date of Patent: August 14, 2001Assignees: The University of New South Wales, Burns Philp & Company Limited, Burns Philp Research & Development Pty Ltd., Commonwealth Scientific and Industrial Research Organisation, Arnott's Biscuits Limited, Gist-Brocades Austrialia Pty Limited, Goodman Fielder Ingredients LimitedInventors: Ian L. Brown, Patricia Lynne Conway, Karl Anders Olof Henriksson, Kenneth J. McNaught, Xin Wang
-
Patent number: 6221350Abstract: Probiotic composition comprising one or more probiotic microorganisms, a carrier which will function to transport the one or more probiotic microorganisms to the large bowel or other regions of the gastrointestinal tract of an animal, the carrier comprising a modified or unmodified resistant starch or mixtures thereof, which carrier acts as a growth or maintenance medium for microorganisms in the large bowel or other regions of the gastrointestinal tract, and an oligosaccharide. Method of increasing the number of probiotic or resident microorganisms in the gastrointestinal tract of an animal comprising providing to the animal the probiotic composition.Type: GrantFiled: April 12, 1999Date of Patent: April 24, 2001Assignees: The University of New South Wales, Burns Philip & Company Limited, Burns Philip Research & Development PTY LTD, The Commonwealth of Australia Commonwealth Scientific and Industrial Research Organization, Arnott's Biscuits Limited, Gist-Brocades Australia PTY Limited, Goodman Fielder Ingredients LimitedInventors: Ian L. Brown, Patricia Lynne Conway, David Lloyd Topping, Xin Wang
-
Patent number: 6129923Abstract: The application discloses a method for the treatment of Heliobacter infection in a mammalian host, which comprises administration to said infected host of an immunologically effective amount of one or more Heliobacter antigen(s), optionally in association with a mucosal adjuvant.Type: GrantFiled: October 29, 1998Date of Patent: October 10, 2000Assignees: CSL Limited, The University of New South WalesInventors: Christopher Vincent Doidge, Adrian Lee
-
Patent number: 6060050Abstract: A probiotic composition is disclosed which is particularly useful for inclusion in food products to enhance their nutritional value. The composition comprises one or more probiotic microorganisms such as Bifidobacterium and a carrier to transport the microorganisms to the large bowel or other regions of the gastrointestinal tract. The carrier is a modified or unmodified resistant starch, particularly a high amylose starch, which acts as a growth or maintenance medium for microorganisms in the large bowel or other regions of the gastrointestinal tact.Type: GrantFiled: June 17, 1997Date of Patent: May 9, 2000Assignees: The University of New South Wales, Burns Philp & Company Limited, Burns Philp Research & Development PTY Limited, Gist-Brocades Australia PTY Limited, Commonwealth Scientific and Industrial Research Organisation, Arnott's Biscuits Limited, Goodman Fielder Ingredients Limited, Goodman Fielder LimitedInventors: Ian L Brown, Kenneth J McNaught, Robert N Ganly, Patricia Lynne Conway, Anthony John Evans, David Lloyd Topping, Xin Wang
-
Patent number: 6005090Abstract: An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the catalase enzyme of Helicobacter bacteria, particularly the catalase enzyme of H. pylori or H. felis, or an immunogenic fragment thereof.Type: GrantFiled: August 15, 1996Date of Patent: December 21, 1999Assignees: The University of New South Wales, CSL LimitedInventors: Christopher V. Doidge, Adrian Lee, Flona J. Radcliff, Stuart L. Hazell
-
Patent number: D557632Type: GrantFiled: April 18, 2006Date of Patent: December 18, 2007Assignees: Ventrassist Pty Ltd., The University of New South WalesInventor: Minh Lee
-
Patent number: D616552Type: GrantFiled: November 14, 2005Date of Patent: May 25, 2010Assignees: Ventrassist Pty Ltd., University of New South WalesInventors: Minh Lee, Peter Joseph Ayre